| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 9.5e-06 | 1 |